clinical study insights

Hematology

Thrombopoietin Receptor Agonists Maintain Platelet Counts and Induce Remission in Patients With Chronic Immune Thrombocytopenia

clinical study insights
By Howard A. Liebman, MD
Inducing Remission in Chronic Immune Thrombocytopenia
Hematology

Inducing Remission in Chronic Immune Thrombocytopenia

clinical study insights
By Adam Cuker, MD, MS; Howard A. Liebman, MD; Terry B. Gernsheimer, MD
Updates on Second-Line Therapies for Immune Thrombocytopenia
Hematology

Updates on Second-Line Therapies for Immune Thrombocytopenia

clinical study insights
By Terry B. Gernsheimer, MD
Long-Term Efficacy and Safety of the Thrombopoietin Receptor Agonist Eltrombopag
Hematology

Long-Term Efficacy and Safety of the Thrombopoietin Receptor Agonist Eltrombopag

clinical study insights
By Howard A. Liebman, MD
The VAST-D Study: Augmentation Versus Switching Treatments for Optimizing Treatment of Depression
Psychiatry

The VAST-D Study: Augmentation Versus Switching Treatments for Optimizing Treatment of Depression

clinical study insights
By Michael E. Thase, MD
Load More